echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > China Exhibition of world pharmaceutical raw materials promotes the development of the industry

    China Exhibition of world pharmaceutical raw materials promotes the development of the industry

    • Last Update: 2011-06-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Business club, June 14 the 11th world pharmaceutical raw materials China Exhibition (cphichina 2011) will be held in Shanghai on June 21 CPHI China exhibition, which mainly focuses on intermediates and APIs, together with p-mec China Exhibition (world pharmaceutical machinery, packaging equipment and materials China Exhibition), has become the largest annual event in the pharmaceutical industry in Asia, greatly boosting the development of related industries Industry development promotes the upgrading of CPHI China exhibition since it was held in Shanghai in 2001, it has been the 11th annual exhibition so far, and now it has become the largest pharmaceutical raw materials exhibition in Asia and the second in the world One of the organizers of the exhibition, China Pharmaceutical (600056, Cui bin, Secretary General of the chamber of Commerce for health care products import and export, intuitively demonstrated the development pace of CPHI China in 11 years through a series of figures: the scale of the exhibition has been expanding continuously, only 6000 square meters in 2001, 85000 square meters in 2010, and 100000 square meters this year, the most in the past; the number of exhibitors has been increasing, only 200 enterprises participated in 2001, and domestic and foreign exhibitors in 2010 There are 1719 visitors, which will reach about 2000 this year; the number of visitors is increasing year by year, with only 8000 visitors in 2001 and 26000 professional visitors in 2010, including more than 7800 overseas visitors Cui bin told reporters that the growth of CPHI China exhibition is closely related to the rapid development of the industry, and the development of the industry also puts forward new demands for the exhibition, so as to promote the continuous upgrading of the exhibition From the first single pharmaceutical raw materials exhibition to the joint pharmaceutical machinery, packaging equipment and materials exhibition in China, then to the world contract customization service exhibition in China, the world biochemical, analytical instruments and laboratory equipment exhibition in China, the natural extract area, the pharmaceutical packaging materials boutique area, and the connotation of CPHI China exhibition has been expanding CPHI series China exhibition, sponsored by Europe Bowen exhibition Consulting Co., Ltd and China Chamber of Commerce for the import and export of medical and health products, CO organized by Shanghai Bohua International Exhibition Co., Ltd., has created a one-stop platform for the industry, mainly displaying products such as APIs, chemicals and intermediates, excipients and agents, natural extracts, contract R & D outsourcing, contract production outsourcing, reagents, biotechnology, etc To help exhibitors reach customers from all over the world, and help purchasers purchase comprehensive products, advanced services and related technologies at preferential prices Merck, rogate, Johnson Matthey, romenhas, Evonik Degussa, Novartis, Sinopharm, Sinopharm, Harbin pharmaceutical, Dongyao, Shangyao, Haizheng, Huahai, Lukang and other domestic and foreign leading enterprises have become regular exhibitors of CPHI China exhibition The exhibitors gave high recognition to the exhibition, and thought it was a good opportunity to do foreign trade without going abroad, a place to contact customers' feelings, a bridge to meet new customers, and a platform to promote products and understand the industry wind direction CPHI series also witnessed the rapid development of China's pharmaceutical foreign trade industry China's API export has also stepped out of the shadow of the international financial crisis, and has begun to enter a new round of rising channels The export volume of 24 kinds of APIs in China increased from 109000 tons in 2001 to 400000 tons in 2009 In 2010, the overall export volume and price of API of Western medicine rose, and the mainstream market developed in a balanced way China has developed into the world's largest producer and exporter of APIs At present, there are 4696 enterprises producing APIs and preparations, which can produce more than 1500 APIs and 4000 chemicals In 2010, 83% of the 65 key export chemical APIs increased in export volume and 57% in export price Cui bin predicted that in 2011, API exports will shift from rapid recovery growth to stable growth, driven by the continued expansion of market share in Europe and the United States and the growth of demand in emerging markets, with the growth expected to remain at about 20% As one of the organizers of CPHI China exhibition, China Medical Insurance chamber of commerce is committed to building a good communication platform for exhibitors and merchants As the only trade promotion agency in China's pharmaceutical import and export industry, the medical insurance chamber of Commerce has a more profound consideration for using the exhibition platform to serve the industry In the face of endless system revision, management updating and strengthening supervision, how can enterprises meet the opportunities and challenges under the policy and system adjustment? How can the regulatory authorities correctly guide enterprises to the standardized production and operation path? In the context of enterprises and governments eager to strengthen communication, the "China world pharmaceutical forum" of CPHI China came into being "To realize zero distance communication between enterprises and the government through holding the forum is one of our measures to extend exhibition services, and this year the forum will continue to be held At that time, experts and scholars from China's Ministry of Commerce, the State Food and Drug Administration and other authoritative departments and industries will conduct in-depth interpretation and Analysis on the trend of pharmaceutical import and export during the 12th Five Year Plan period, a new round of integration trend of pharmaceutical circulation industry and how enterprises should respond to intellectual property protection and other issues " Cui bin told reporters The chamber of health insurance will also organize professional sub forums according to the needs of enterprises, such as pharmaceutical equipment sub forum, China plant extract development and innovation forum, among which "China plant extract development and Innovation Forum" is the sixth one this year Professional forum for enterprises and experts to build a communication channel, where enterprises can get the most cutting-edge industry information According to Cui bin, the trade matching negotiation activity is also one of the service projects carefully planned by the medical insurance chamber of Commerce for enterprises Before the exhibition every year, the chamber of Commerce of medical insurance will carefully study the visiting overseas delegations, sort out their needs, find qualified and interested enterprises among the exhibitors, arrange the two sides to meet during the exhibition, and carry out one-to-one trade matching negotiation activities The Japanese delegation organized by the Japan Pharmaceutical Trade Association has participated in three consecutive sessions of CPHI China exhibition President of the association, Xiuxiong Kada, once said that the trade matching negotiation was very popular, and they will continue to do something for the exchange and development of the Chinese and Japanese pharmaceutical industry It can be said that CPHI China exhibition is an excellent international platform for the majority of pharmaceutical enterprises to "show, trade, exchange and cooperate" At the same time, it also promotes domestic pharmaceutical enterprises to go to the international market, promotes the prosperity of Pharmaceutical Foreign Trade and the rapid development of the entire pharmaceutical industry According to IMS, China's drug market will reach US $50 billion in 2011, becoming the third largest medical consumer market in the world There is no doubt that China's pharmaceutical industry has entered a golden period of development Cui bin expressed that he believed that with the concerted efforts of the organizers and the organizers of the exhibition and the enthusiastic participation of the exhibitors and purchasers, CPHI China exhibition will make another brilliant innovation in the "golden decade of medicine".
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.